✦ LIBER ✦

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial

✍ Scribed by B. Göke; B. Gallwitz; J. Eriksson; Å. Hellqvist; I. Gause-Nilsson; for the D1680C00001 Investigators

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparison of efficacy and safety of v

✍ C. Filozof; J.-F. Gautier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

2-year efficacy and safety of linaglipti

✍ Baptist Gallwitz; Julio Rosenstock; Thomas Rauch; Sudipta Bhattacharya; Sanjay P 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 289 KB

Nateglinide or gliclazide in combination

✍ S. Ristic; C. Collober-Maugeais; F. Cressier; P. Tang; E. Pecher 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Efficacy and safety of the dipeptidyl pe

✍ M. A. Nauck; G. Meininger; D. Sheng; L. Terranella; P. P. Stein; Sitagliptin Stu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Long-term treatment with the dipeptidyl

✍ M. Nowicki; I. Rychlik; H. Haller; M. Warren; L. Suchower; I. Gause-Nilsson; K-M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Addition of either pioglitazone or a sul

✍ O. Vaccaro; M. Masulli; E. Bonora; S. Del Prato; C.B. Giorda; A.P. Maggioni; P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 241 KB